PATH-49. CLINICAL UTILITY OF PLASMA CELL-FREE DNA IN ADULT PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA – A PILOT PROSPECTIVE STUDY

BACKGROUND: Liquid biopsy has been not been widely utilized in patients with glioblastoma (GBM) compared to other solid tumors. However, the clinical utility of plasma cell-free DNA (cfDNA) in GBM has not been assessed prospectively or at the time of initial diagnosis. METHODS: We conducted a prospe...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Neuro Oncol
Autores principales: Bagley, Stephen, Nabavizadeh, Seyed, Mays, Jazmine, Till, Jacob, Yee, Stephanie, Ware, Jeffrey, Guiry, Samantha, Nasrallah, MacLean, Levy, Scott, Sarchiapone, Whitney, Hussain, Jasmin, Prior, Timothy, Cucciara, Andrew, Binder, Zev, O’Rourke, Donald, Brem, Steven, Desai, Arati, Carpenter, Erica
Formato: Artigo
Lenguaje:Inglês
Publicado: Oxford University Press 2019
Materias:
Molecular Pathology and Classification - Adult and Pediatric
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6847468/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noz175.645
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares